Narjust Florez: What Happens at ELIXR 2026 Shapes Tomorrow’s Lung Cancer Research
Narjust Florez/X

Narjust Florez: What Happens at ELIXR 2026 Shapes Tomorrow’s Lung Cancer Research

Narjust Florez, Co-Director of Young Lung Cancer Program at Dana-Farber Cancer Institute, shared a post on X:

“What happens at ELIXR… becomes tomorrow’s grant, next year’s trial, and next week’s inbox.

Early-stage lung cancer.

Narjust Florez

Other articles about Lung Cancer on OncoDaily.